- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Nexgel regains Nasdaq minimum bid price compliance | 1 | Investing.com | ||
| Di | NEXGEL regains compliance with Nasdaq | 1 | Seeking Alpha | ||
| NEXGEL Aktie jetzt für 0€ handeln | |||||
| Di | NEXGEL, INC.: NEXGEL Regains Compliance with Nasdaq Listing Requirement | 1 | GlobeNewswire (USA) | ||
| 12.10. | NEXGEL, INC.: NEXGEL Announces 1-for-20 Reverse Stock Split Effectiveness | 3 | GlobeNewswire (USA) | ||
| 07.10. | NEXGEL, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 23.09. | NexGel: Aktionäre genehmigen Kapitalerhöhung und Reverse Stock Split | 1 | Investing.com Deutsch | ||
| 23.09. | NEXGEL, INC. - 8-K, Current Report | 18 | SEC Filings | ||
| 23.09. | NEXGEL, INC.: NEXGEL Announces Dial-In Details for Investor Update Call | 2 | GlobeNewswire (USA) | ||
| 16.09. | NEXGEL, INC.: NEXGEL Announces Date for Investor Update Call | 1 | GlobeNewswire (USA) | ||
| 20.08. | NEXGEL appoints Brian Kieser as interim CEO after Adam Levy steps down | 1 | Seeking Alpha | ||
| 20.08. | NEXGEL, INC. - S-1, General form for registration of securities | 1 | SEC Filings | ||
| 19.08. | NEXGEL Recalls SilverSeal From Amazon To Launch Product Into Higher-Margin Hospital Market | 5 | pulse2.com | ||
| 17.08. | NEXGEL reports Q2 results | 2 | Seeking Alpha | ||
| 17.08. | NEXGEL, INC. - 8-K, Current Report | 6 | SEC Filings | ||
| 29.07. | NEXGEL, INC. - 8-K, Current Report | 4 | SEC Filings | ||
| 02.07. | NEXGEL, INC. - 8-K, Current Report | 2 | SEC Filings | ||
| 17.06. | NEXGEL, INC. - 8-K, Current Report | 4 | SEC Filings | ||
| 19.05. | Nexgel hydrogel patch reduces laser plume in hair removal study | 8 | Investing.com | ||
| 19.05. | NEXGEL, INC.: NEXGEL Reports Positive Data from Randomized Single-Center IRB Study to Evaluate the Effectiveness and Safety of a Hydrogel Laser Treatment Patch in Laser Hair Removal with a 95.6% Reduction in Plume Concentration | 1 | GlobeNewswire (USA) | ||
| 15.05. | Earnings Call zu Q1 2026: Nexgel meldet Umsatzrückgang, Aktie gibt nach | 2 | Investing.com Deutsch |
1 2 Weiter >>
33 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 7,558 | -0,55 % | Stifel hebt Kursziel für Teladoc Health an: Kostensenkungen stärken Margen | ||
| SERNOVA BIOTHERAPEUTICS | 0,067 | +1,52 % | Sernova Biotherapeutics, Inc.: Sernova and Seraxis Close US$11.2 Million Financing to Fund Merger to Become BetaNova Biotherapeutics and Advance Type 1 Diabetes Cell Therapy Into Near Term Phase 1/2 Clinical Trial | TORONTO and GERMANTOWN, Md., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics Inc. ("Sernova") (TSX: SVA) (OTC: SEOVF) (FSE/XETRA: PSHO) and Seraxis Holdings, Inc. ("Seraxis") today announced... ► Artikel lesen | |
| CERENOME | 1,458 | -0,14 % | Cerenome completes enrollment in glioblastoma drug trial | ||
| ATOSSA THERAPEUTICS | 2,120 | +8,72 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Aug. 7, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2026 -5- | The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2026ISIN NameUS75973T2006 RENALYTIX... ► Artikel lesen | |
| TANDEM DIABETES | 17,700 | +0,57 % | Tandem Diabetes Care, Inc.: Tandem Mobi Automated Insulin Delivery System Now Available in Twelve International Markets | Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that Tandem Mobi, the world's smallest, durable automated insulin delivery... ► Artikel lesen | |
| CO-DIAGNOSTICS | 0,369 | +0,52 % | Co-Diagnostics' Joint Venture CoSara Diagnostics Completes Clinical Study and Regulatory Submission for Point-of-Care Tuberculosis Test, Sets Stage for Commercial Launch in India | CDSCO Clearance and Commercial Launch in India Anticipated Before Year-End 2026Study Demonstrated 97.3% Sensitivity and 96.0% SpecificityConsistent Performance Across Three Test BatchesIntegrated Mobile... ► Artikel lesen | |
| QUIDELORTHO | 11,315 | -4,56 % | QuidelOrtho Corporation: QuidelOrtho Reports Second Quarter 2026 Financial Results | ? Total revenue grew 3% reported and 2% constant currency, primarily driven by Labs and Point of Care growth ?
? Excluding China, total revenue grew 6% both as... ► Artikel lesen | |
| VERU | 2,190 | 0,00 % | Oppenheimer reiterates Veru stock rating ahead of obesity trial data | ||
| LIFEWARD | 5,910 | -0,51 % | Lifeward Ltd. - 8-K, Current Report | ||
| CLOVER HEALTH INVESTMENTS | 3,890 | -2,51 % | Clover Health im Aufwind: Needham startet Coverage mit "Buy" und Kursziel von 6 Dollar | ||
| SENSEONICS | 8,500 | 0,00 % | Senseonics Holdings, Inc.: Senseonics Initiates First-in-Human Study of Freedom, Designed to be the World's First CGM System with No On-body Component | ||
| NANO-X IMAGING | 0,330 | 0,00 % | Nano-X Imaging Ltd. - 6-K, Report of foreign issuer | ||
| TEMPEST THERAPEUTICS | 0,500 | +0,87 % | Tempest Therapeutics, Inc. - 8-K, Current Report | ||
| IMUNON | 0,770 | 0,00 % | Imunon, Inc. - S-1, General form for registration of securities |
Das Unternehmen NEXGEL INC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 3,600 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEXGEL INC finden Sie auf Wallstreet Online.